Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,455 | 156 | 99.7% |
| Education | $8.40 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $422.47 | 25 | $0 (2024) |
| Novo Nordisk Inc | $238.37 | 18 | $0 (2024) |
| Lilly USA, LLC | $234.96 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $230.67 | 16 | $0 (2024) |
| Amgen Inc. | $118.77 | 8 | $0 (2024) |
| Abbott Laboratories | $118.38 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $116.42 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $103.16 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $102.99 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $98.78 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $461.34 | 28 | ABBVIE INC. ($169.48) |
| 2023 | $600.17 | 35 | AbbVie Inc. ($220.66) |
| 2022 | $368.78 | 21 | Lilly USA, LLC ($74.44) |
| 2021 | $328.56 | 18 | Teva Pharmaceuticals USA, Inc. ($68.62) |
| 2020 | $169.64 | 12 | AstraZeneca Pharmaceuticals LP ($43.82) |
| 2019 | $277.43 | 23 | Novo Nordisk Inc ($112.99) |
| 2018 | $162.23 | 14 | AstraZeneca Pharmaceuticals LP ($38.24) |
| 2017 | $95.08 | 7 | Merck Sharp & Dohme Corporation ($39.05) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Durable Pump | ||||||
| 12/12/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: PAIN | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: VACCINE | ||||||
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Inflammation | ||||||
| 06/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Diabetes Care | ||||||
| 05/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Durable Pump | ||||||
| 04/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 340 | 612 | $193,696 | $27,146 |
| 2022 | 5 | 431 | 719 | $167,531 | $32,727 |
| 2021 | 10 | 496 | 781 | $165,363 | $52,478 |
| 2020 | 12 | 555 | 846 | $172,740 | $46,856 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 303 | $115,140 | $13,822 | 12.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 265 | $70,755 | $11,117 | 15.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 13 | $1,326 | $985.53 | 74.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $5,404 | $721.62 | 13.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,071 | $499.12 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 358 | $97,104 | $16,963 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 271 | $55,494 | $12,079 | 21.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $13,972 | $3,275 | 23.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $621.00 | $365.06 | 58.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 20 | 20 | $340.00 | $44.55 | 13.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 205 | 388 | $99,328 | $31,692 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 138 | 224 | $43,456 | $13,116 | 30.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 15 | 15 | $3,600 | $1,961 | 54.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 26 | 26 | $2,600 | $1,692 | 65.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $5,440 | $1,352 | 24.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 20 | 21 | $4,074 | $862.13 | 21.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 11 | 22 | $2,728 | $707.08 | 25.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 17 | 20 | $2,560 | $552.62 | 21.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 31 | $1,271 | $501.77 | 39.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 17 | 18 | $306.00 | $40.50 | 13.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 205 | 399 | $102,144 | $25,752 | 25.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 127 | 190 | $36,860 | $8,383 | 22.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 39 | 50 | $7,702 | $2,773 | 36.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 28 | 29 | $6,149 | $2,466 | 40.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 33 | 34 | $3,400 | $2,061 | 60.6% |
About Dr. Matthew Studebaker, M.D
Dr. Matthew Studebaker, M.D is a Family Medicine healthcare provider based in Hillsboro, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487752531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Studebaker, M.D has received a total of $2,463 in payments from pharmaceutical and medical device companies, with $461.34 received in 2024. These payments were reported across 158 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,455).
As a Medicare-enrolled provider, Studebaker has provided services to 1,822 Medicare beneficiaries, totaling 2,958 services with total Medicare billing of $159,206. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hillsboro, OH
- Active Since 09/20/2006
- Last Updated 12/24/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487752531
Products in Payments
- Ozempic (Drug) $190.14
- QULIPTA (Drug) $184.82
- FARXIGA (Drug) $167.37
- UBRELVY (Drug) $126.74
- XIFAXAN (Drug) $116.42
- NURTEC ODT (Drug) $115.64
- VRAYLAR (Drug) $110.91
- Aimovig (Biological) $100.71
- TRULICITY (Drug) $91.56
- FREESTYLE LIBRE 2 (Device) $85.44
- MOUNJARO (Drug) $84.20
- TRELEGY ELLIPTA (Drug) $75.93
- AirDuo Digihaler (Drug) $68.62
- XARELTO (Drug) $65.05
- Cologuard Collection Kit (Device) $62.88
- TRINTELLIX (Drug) $45.37
- JARDIANCE (Drug) $44.85
- Trintellix (Drug) $43.30
- CHANTIX (Drug) $42.20
- JANUVIA (Drug) $39.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hillsboro
Dr. David Stansfield, Do, DO
Family Medicine — Payments: $10,120
Dr. Danielle Shapiro, Md, MD
Family Medicine — Payments: $6,386
Jacob Yankowitz, Do, DO
Family Medicine — Payments: $4,506
Traci Ackron, D.o, D.O
Family Medicine — Payments: $3,715
Timothy Luithle, Md, MD
Family Medicine — Payments: $2,472
Marc Lewis, M.d, M.D
Family Medicine — Payments: $2,345